Entourage Extends Supply Deal With Tilray's HEXO To Ensure Top-Quality Cannabis Products

Canadian producer and distributor of cannabis products Entourage Health Corp. ENTG ETRGF (FSE:4WE) has entered into an amended supply agreement with HEXO Corp.

The amendments extend the initial term of the agreement, securing Entourage's ongoing access to high-quality bulk cannabis biomass for its product portfolio.

The prices of all products supplied under the supply agreement are fixed but subject to limited and periodical adjustments depending on prevailing production costs.

Following the acquisition of HEXO by Tilray Brands Inc. TLRY earlier this year, Entourage shifted its sourcing strategy, now obtaining bulk cannabis from Tilray cultivation sites.

"Our partnership with HEXO has consistently delivered impressive results," said George Scorsis, CEO and chair. "Moving ahead with Tilray, a highly respected company, we share a common goal - to develop a partnership deeply rooted in our promise to ensure our products continue to meet and exceed the highest standard of quality and satisfaction for our patients and consumers."

Additionally, HEXO's obligations under the deal have been assigned to Aphria Inc., Tilray's principal operating entity and license holder.

In June, Tilray CEO Irwin D. Simon, who has been a keynote speaker at past Benzinga Cannabis Capital Conferences, said HEXO will boost Tilray's "competitive positioning."

The Benzinga Cannabis Capital Conference, the place where deals get done, is returning to Chicago this Sept 27-28 for its 17th edition. Get your tickets today before prices increase and secure a spot at the epicenter of cannabis investment and branding.

Related News

• Entourage Health Q1 Revenue Declines 4.8% YoY, What About Adjusted EBITDA?
• Entourage Health Reports FY22 Revenue of $54.5M, Loss Of $123.15M
• Entourage Health Launches CBD Chewing Gum And Signs New Union Group To The Starseed Medicinal Program

Photo: Courtesy of Esteban López on Unsplash